These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 523590)

  • 1. Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy: growth hormone and prolactin response to stimuli.
    Brambilla F; Bellodi L; Negri F; Smeraldi E; Malagoli G
    Psychoneuroendocrinology; 1979 Oct; 4(4):329-39. PubMed ID: 523590
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective dopamine D2 antagonist and prolactin response in acute schizophrenia--results from remoxipride studies. The Canadian Remoxipride Study Group.
    Awad AG; Lapierre YD; Jostell KG
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):769-77. PubMed ID: 2149882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A neuroendocrine study of supersensitivity in tardive dyskinesia.
    Tamminga CA; Smith RC; Pandey G; Frohman LA; Davis JM
    Arch Gen Psychiatry; 1977 Oct; 34(10):1199-203. PubMed ID: 911219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and prolactin stimulation by Madopar in Parkinson's disease.
    Martinez-Campos A; Giovannini P; Parati E; Novelli A; Caraceni T; Müller EE
    J Neurol Neurosurg Psychiatry; 1981 Dec; 44(12):1116-23. PubMed ID: 7334406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of dopamine receptor blockade to clinical response in schizophrenic patients treated with pimozide or haloperidol.
    Silverstone T; Cookson J; Ball R; Chin CN; Jacobs D; Lader S; Gould S
    J Psychiatr Res; 1984; 18(3):255-68. PubMed ID: 6387105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
    Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
    Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol and droperidol treatment in schizophrenics. Clinical application of the "prolactin-model".
    Langer G; Pühringer W
    Acta Psychiatr Belg; 1980; 80(5):574-83. PubMed ID: 7234451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin responses to haloperidol in drug-free and treated schizophrenic patients.
    Markianos M; Sakellariou G; Bistolaki E
    J Neural Transm Gen Sect; 1991; 83(1-2):37-42. PubMed ID: 2018629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroendocrinology and schizophrenia research].
    Müller-Spahn F
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1991; 64():1-96. PubMed ID: 1682802
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-induced growth hormone and prolactin responses in schizophrenia research.
    Lal S; Nair NP; Iskandar HI; Thavundayil JX; Etienne P; Wood PL; Guyda H
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):631-7. PubMed ID: 6131495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin-induced increase in growth hormone response to levodopa in adult males.
    D'Alessandro R; Cortelli P; Gallassi R; Ghisoli E; Montanaro N; Zoni E; Baruzzi A
    J Neurol Neurosurg Psychiatry; 1984 Jul; 47(7):715-9. PubMed ID: 6431057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone and prolactin secretion in liver cirrhosis: evidence for dopaminergic dysfunction.
    Borzio M; Caldara R; Ferrari C; Barbieri C; Borzio F; Romussi M
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):441-7. PubMed ID: 7270004
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia.
    Nair NP; Lal S; Cervantes P; Yassa R; Guyda H
    Neuropsychobiology; 1979; 5(3):136-42. PubMed ID: 431802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of apomorphine on blood levels of homovanillic acid, growth hormone and prolactin in medicated schizophrenics and healthy control subjects.
    Scheinin M; Syvälahti EK; Hietala J; Huupponen R; Pihlajamäki K; Seppälä OP; Säkö E
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):441-9. PubMed ID: 2866563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man.
    Meltzer HY; Fleming R
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):76-9. PubMed ID: 6130077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion.
    Lal S; Nair NP; Cervantes P; Pulman J; Guyda H
    Acta Psychiatr Scand; 1979 Feb; 59(2):173-9. PubMed ID: 420037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Controlled study of L-dopa in schizophrenia with reference to the theory of hypersensitivity of dopamine receptors].
    Beramendi V; Alpert M; Guimón J; Friedhoff A; Gutiérrez M
    Arch Neurobiol (Madr); 1980; 43(2):107-24. PubMed ID: 6996632
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect on plasma prolactin, growth hormone and luteinising hormone concentrations of single oral doses or propranolol and tolamolol in normal man.
    Saxton CA; Faulkner JK; Groom GV
    Eur J Clin Pharmacol; 1981; 21(2):103-8. PubMed ID: 6896183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulatory control of prolactin by dopamine.
    Brown GM; Seggie JA
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):355-8. PubMed ID: 6891802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder.
    Chou JC; Douyon R; Czobor P; Volavka J; Cooper TB
    Psychiatry Res; 1998 Oct; 81(1):51-5. PubMed ID: 9829650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.